Similarly to obesity, leptin was shown to correlate with increased prostate cancer risk and developing of larger tumours, while the data linking leptin levels with prostate cancer incidence is inconclusive. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.